EMV vs PAR

ASX Healthcare sector comparison — updated 14 Jul 2026 — Healthcare sector

EMV

EMVISION FPO [EMV]

51MEDIUM

PAR

PARA BIO FPO [PAR]

48LOW

Score Breakdown

EMV PAR
Technical
65
53
Catalyst
50
51
Sentiment
50
50
Fundamental
70
60
Momentum
39
42
Risk Gate
50
50

Key Metrics

EMV Metric PAR
$139.9MMarket Cap$99.4M
37KAvg Volume (20d)2.2M
N/AShort InterestN/A
$2.43052-Week High$0.470
$1.47052-Week Low$0.135
+3.0%Daily Change-7.4%
$1.550Reference Price$0.162
-58.0%ROE-180.2%
-188.0%Profit MarginN/A

Active Signals

EMV Signals

MACD momentum is picking up steam
Bollinger Bands are tightening — volatility is coiling up for a potential breakout
Below the 200-day average — the long-term trend is still working against it
Adequate cash runway (8 quarters)
Moderate revenue growth (+11%)
EPS estimates revised upward (+6pts)
Near 52-week low (4% of range)
Deeply negative margins (-188%)

PAR Signals

RSI drifting toward oversold territory — worth watching
Bollinger Bands are tightening — volatility is coiling up for a potential breakout
Drifting lower — down 4.7% over the last 5 days
Volatility is contracting — like a spring being compressed, breakouts often follow
Below the 200-day average — the long-term trend is still working against it
Low cash runway (2 quarters) - dilution risk
Very high P/S ratio (11766.1x)
Strong revenue growth (+51%)

Ask Scout AI to compare EMV and PAR in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

EMV vs PEB →EMV vs SPL →ENL vs HIQ →ENL vs LGP →ENL vs MSB →
EMV Full Analysis → PAR Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).